BRAINBiocatalysts Life Science Solutions:
Enzyme Solutions for Small Molecule APIs and Biologics
Your flexible end-to-end enzyme development and scale-up partner for small molecule API and biologics production
At BRAINBiocatalysts, we specialise in delivering innovative enzyme solutions tailored for the pharmaceutical industry. Our comprehensive capabilities enable our partners to accelerate drug development, safeguard their intellectual property, and seamlessly scale from enzyme discovery to full-scale production. Whether you're developing next-generation therapies or advancing pharmaceutical processes, we're here to ensure your success at every step of the journey. By leveraging the strengths of both companies, we simplify biocatalysis, delivering tailored, scalable solutions that ensure your product, your IP, and your future are fully supported.
End-to-end partner for enzyme solutions
The only company offering complete adaptable enzyme development and scale-up solutions to support the evolving need of the life science industry
Your Product | Your IP | Your Future
Related Media
12 Nov 2025
Reflections from CPHI 2025: Enzyme Innovation at the Heart of Pharmaceutical Progress
From sustainable biocatalysis to AI-driven enzyme discovery and the ongoing challenge of scaling up from lab to production, CPHI 2025 showcased how fast the industry is evolving, and how collaboration between discovery, strain development, and process engineering is now critical for real progress. Read our full event round up.
21 Aug 2025
Unlocking the Power of Biocatalysis for Complex Molecules and Novel Modalities
From chiral amines and nucleoside analogues to non-canonical amino acids and oligonucleotides, pharmaceutical pipelines are evolving - and so must the tools that support them.
9 Jul 2025
Reflections from Biotrans 2025: Charting the Future of Biocatalysis in Pharmaceuticals
More than 650 industry leaders, academic pioneers, and technology disruptors travelled to Basel to the most impactful biocatalysis conference of the year. Read our take on the key discussions, trends and industry challenges from Biotrans 2025.
20 Jun 2025
Strain Engineering & Optimisation Driving Pharmaceutical and Life Science Innovation
In pharmaceutical and life science applications, enzymes aren’t just molecules they’re critical tools driving innovation in therapeutics, diagnostics, and bioprocessing. But without the right production strain, even the most promising enzyme can fail to scale.
16 Jun 2025
Addressing Bioprocess Challenges in Enzyme Development for Pharmaceuticals
From strain engineering to scalable fermentation and downstream purification, we help pharmaceutical and life science companies build robust, reproducible processes that accelerate time to market and reduce risk. Discover our recent success and how we can strengthen your bioprocess development.
4 Jun 2025
The Importance of Production Strains in Enzyme Manufacture
Efficient, high-yield enzyme manufacturing doesn’t just depend on what you produce, but how you produce it. The production strain is the unsung hero of industrial bioprocessing, determining yield, quality, and scalability.
16 May 2025
From AI to Application: Turning Enzyme Discovery into Scalable Reality
AI is revolutionising enzyme discovery - but turning predictions into real-world products is where the challenge begins. We explore the missing link between enzyme design and scalable, industrial application.
9 May 2025
SynBioBeta 2025: Key Industry Trends and Challenges in Synthetic Biology
Synthetic biology is no longer the future - it's reshaping industries today. At SynBioBeta 2025, global innovators came together to explore how AI is accelerating biological discovery and transforming fields from healthcare to biomanufacturing.
18 Nov 2022
Biocatalysts awarded in Top 10 Synthetic Biology Companies 2022 by Life Sciences Review!
We're very pleased to receive this esteemed award from Life Sciences Review in their annual listing of 10 companies that are at the forefront of providing Synthetic Biology solutions and transforming businesses.
Case Study
Partnering with a Global Pharmaceutical Company for Large Scale Enzyme Manufacturing
A large pharmaceutical company needed an enzyme manufacturing partner to develop their enzymes from lab to commercial scales.
